A maker of the ultrapure materials, chemicals, and handling gear that go into making computer chips, Entegris keeps silicon wafers clean and flat during fabrication, supplying things like CMP slurries, specialty gases, and wafer carriers to chipmakers worldwide. The company traces back to 1966's Fluoroware, which made Teflon-based containers for early microelectronics, and took its current name in 1999 after merging with EMPAK. Fun fact: "Entegris" blends "integrity" and "ingenuity" — a nod to keeping microscopic circuitry flawless.
Entegris Q2 FY2026 revenue rose 11.5% to $883.2M with gross margin up 320bps to 47.6%.
Both segments returned to growth this quarter after a year of declines. rose 11.5% to $883.2M and expanded 3.2 points to 47.6% as volume grew and a $73M annual reduction took effect, with up 74.3% to $0.61. The company has reversed the margin erosion that ran through FY2025 and is paying down debt.
Key takeaways
expanded 320 to 47.6%, benefiting from increased production volumes and a $73M annual reduction in expense from extended asset useful lives.
Consolidated rose 11.5% to $883.2M and 8.8% sequentially, driven by higher volumes in both the Materials Solutions and Advanced Purity Solutions segments.
Advanced Purity Solutions sales grew 17% to $514.6M with up 57% to $150.9M on liquid/gas filtration, FOUPs, and fluid management solutions.
Section summaries
Management's Discussion and Analysis
Q2 FY2026 net sales rose 11.5% to $883.2M with gross margin up 320bps to 47.6%, driven by volume growth and lower depreciation.
⌄
Consolidated increased 11.5% to $883.2M, primarily from higher volumes in both the Materials Solutions (MS) and Advanced Purity Solutions (APS) segments.
Materials Solutions sales rose 5% to $371.3M led by advanced deposition materials and CMP consumables, with up 7% to $77.7M.
rose 77.3% to $93.6M and rose 74.3% to $0.61; was $339.2M for the first half of FY2026.
The company repaid $250M of term loans, cut 12.2% to $3,456.0M, and amended its to $750M maturing in 2031.
What changed
Q2 FY2026 of 47.6% confirmed the reversal flagged after Q1's 46.9%: margin rose for a second straight quarter after four quarters of decline or flatness from the 44.4% FY2025 level.
growth of 11.5% reversed the prior-year Q2 decline of 2.5% and the flat-to-down trend across FY2025; Q1 FY2026 had risen 5%, so the acceleration to 11.5% widened the recovery.
The $73M reduction management expected in FY2025 to lift margin by ~$52.4M is now flowing, with at 47.6% versus 44.4% a year earlier.
was $116.9M in Q2, down 17.4% sequentially but up 148.7% , against the ~$325M 2026 plan as new facilities ramp.
Top-ten customer concentration at 50% of sales and TSMC at 16% carried from the FY2025 risk factors with no change disclosed this quarter.
What to watch
Q3 FY2026 to see if 47.6% holds as Taiwan, Colorado Springs, and South Korea facility ramp costs develop.
Quantified Q2 2026 impact of U.S. tariffs and China export controls on cost and China-region demand, not disclosed in this filing.
against remaining 2026 after the $116.9M Q2 result and $339.2M half-year .
Any change in top-ten customer orders given 50% concentration and TSMC at 16% of FY2025 sales.
expanded 320bps to 47.6%, benefiting from increased production volumes and a $73M annual reduction in expense due to extended useful lives of property, plant and equipment.
APS sales grew 17% to $514.6M with surging 57% to $150.9M, driven by liquid/gas filtration, FOUPs, and fluid management solutions.
MS sales rose 5% to $371.3M, led by advanced deposition materials and CMP consumables, with up 7% to $77.7M.
was $339.2M for the first half of FY2026; the company repaid $250M of term loans and amended its revolving facility to $750M, extending maturity to 2031.
The company declared a $0.10/share quarterly and reported of $0.93, up 41% .
Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including fluctuations in interest rate and foreign currency exchange rates. For information about our exposure to market risks, see Part II, Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report. The…
⌄
We are exposed to financial market risks, including fluctuations in interest rate and foreign currency exchange rates. For information about our exposure to market risks, see Part II, Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report. There have been no material changes to the market risk disclosures contained therein.
We are, from time to time, involved in various claims, proceedings and lawsuits relating to our business, employees, intellectual property and other matters arising in the ordinary course of business. The Company believes the final outcome of these matters will not have a materi…
⌄
We are, from time to time, involved in various claims, proceedings and lawsuits relating to our business, employees, intellectual property and other matters arising in the ordinary course of business. The Company believes the final outcome of these matters will not have a material adverse effect on its condensed consolidated financial statements. The Company expenses legal costs as incurred.
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors and other cautionary statements described in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condit…
⌄
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors and other cautionary statements described in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condition or future results. There have been no material changes to the risk factors described in our Annual Report.